期刊
HUMAN MOLECULAR GENETICS
卷 23, 期 25, 页码 6697-6711出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddu388
关键词
-
资金
- National Institutes of Health (NIH) [AR40864, AR44533]
- National Health & Medical Research Council of Australia (NHMRC)
- NHMRC [1046782]
- Pfizer Australia
- Medical Scientist Training Program
- National Research Service Award [NIH F30N5068005]
- NIH [GM 103533]
Mutations in dystrophin lead to Duchenne muscular dystrophy, which is among the most common human genetic disorders. Dystrophin nucleates assembly of the dystrophin-glycoprotein complex (DGC), and a defective DGC disrupts an essential link between the intracellular cytoskeleton and the basal lamina, leading to progressive muscle wasting. In vitro studies have suggested that dystrophin phosphorylation may affect interactions with actin or syntrophin, yet whether this occurs in vivo or affects protein function remains unknown. Utilizing nanoflow liquid chromatography mass spectrometry, we identified 18 phosphorylated residues within endogenous dystrophin. Mutagenesis revealed that phosphorylation at S3059 enhances the dystrophin-dystroglycan interaction and 3D modeling utilizing the Rosetta software program provided a structural model for how phosphorylation enhances this interaction. These findings demonstrate that phosphorylation is a key mechanism regulating the interaction between dystrophin and the DGC and reveal that posttranslational modification of a single amino acid directly modulates the function of dystrophin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据